MENU
+Compare
INNPF
Stock ticker: OTC
AS OF
Jul 16 closing price
Price
$0.15
Change
+$0.01 (+7.14%)
Capitalization
86.96M

INNPF Innocan Pharma Corp. Forecast, Technical & Fundamental Analysis

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals... Show more

INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INNPF with price predictions
Jul 16, 2025

INNPF in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 03, 2025

INNPF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 44 cases where INNPF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INNPF advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where INNPF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on July 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on INNPF as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for INNPF turned negative on July 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

INNPF moved below its 50-day moving average on July 16, 2025 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for INNPF entered a downward trend on July 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.406) is normal, around the industry mean (62.813). P/E Ratio (0.000) is within average values for comparable stocks, (89.433). INNPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.074) settles around the average of (0.124) among similar stocks. INNPF's P/S Ratio (208.333) is very high in comparison to the industry average of (19.385).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. INNPF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INNPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

INNPF paid dividends on May 30, 2025

Innocan Pharma Corp. INNPF Stock Dividends
А dividend of $0.73 per share was paid with a record date of May 30, 2025, and an ex-dividend date of May 16, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
13215 Bee Cave Parkway
Phone
+1 512 538-2300
Employees
78
Web
https://www.shpreit.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMVMF28.82N/A
N/A
AMG Advanced Metallurgical Group NV
BCMXY23.95N/A
N/A
Bank of Communications Co. Ltd.
CNBN17.74N/A
N/A
CNB Bank Shares, Inc.
ELCO42.25N/A
N/A
Elcom International, Inc.
MPFRF3.60N/A
N/A
Mapfre SA

INNPF and Stocks

Correlation & Price change

A.I.dvisor tells us that INNPF and HYEX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNPF and HYEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNPF
1D Price
Change %
INNPF100%
-99.17%
HYEX - INNPF
20%
Poorly correlated
N/A
APNHF - INNPF
20%
Poorly correlated
N/A
BIOVF - INNPF
20%
Poorly correlated
+1.85%
KKPCF - INNPF
6%
Poorly correlated
N/A
AYRWF - INNPF
6%
Poorly correlated
+3.33%
More